Table 1 Demographics and disease characteristics in 20 patients with active SLE who were started on Belimumab
From: Real life experience on the effect of Belimumab in patients with active systemic lupus
Mean age | 36+/- 9.2 |
|---|---|
Gender | Female 20 |
Time diagnosis | 1- year 6pts |
1-5 years 11pts | |
6-10 years 3 pts | |
Clinical findings | 9 Pts joint and constitutional symptoms |
7 Pts skin and constitutional symptoms | |
3 Pts joint and hematologic symptoms | |
Ethnicity | Caucasian 20pts |